Little Green Pharma Ltd (ASX:LGP) Directors Insider Transactions
The Directors and Chief Executives of Little Green Pharma Ltd (ASX:LGP) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Little Green Pharma Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Little Green Pharma Ltd to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Little Green Pharma Ltd Directors/Insider Transactions Activity
List of Insider trades activity from Little Green Pharma Ltd (LGP).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 15 Jul 2025 | Fong (Neale William) | Independent Non-Executive Director | 35,000 | - | - |
| 15 Jul 2025 | Lynch-Bell (Michael David) | Independent Non-Executive Chairman | 70,000 | - | - |
| 01 Mar 2025 | Long (Paul) | Managing Director | 3,277,071 | - | - |
| 15 Apr 2024 | Solomon (Fleta Jennifer) | Chief Executive Officer | 36,000 | - | - |
| 03 Apr 2024 | Fong (Neale William) | Independent Non-Executive Director | 35,000 | - | - |
| 03 Apr 2024 | Lynch-Bell (Michael David) | Independent Non-Executive Director | 70,000 | - | - |
| 31 Mar 2024 | Caithness (Angus McDougall) | Director (Executive) | 0 | - | - |